At Novatend, we are committed to advancing tissue engineering and biomaterial solutions to empower healthcare professionals and improve patient outcomes.
To revolutionise regenerative medicine by creating cutting-edge, biocompatible, and cost-effective solutions for your surgical needs. We strive to empower surgeons and patients with reliable products that support natural healing and enhance patient outcomes at an affordable price.
Innovation
Quality
Integrity
Collaboration
Constantly advancing our technology for better solutions.
Delivering clinically proven, reliable products.
Maintaining ethical practices and sustainability.
Partnering with healthcare professionals worldwide.
2022
Launched NovaMEM, a bioresorbable membrane for bone regeneration.
2024
Launched NovaGROW and began building client base after product launch
July
Developed NovaDBMX for the market based on customer demand and expanded clients base
Feb
Founded with a mission to advance tissue engineering and regenerative medicine solutions.
2023
SAHPRA Accreditation to sell devices in the Republic of South Africa
MARCH
55 Private Practices and 4 Day-hospitals regularly use the Nova line of products
2025
Planned Launch of NovaDBM, NovatendX and our orthopaedics division